1. MEC
    November 28, 2012 @ 7:36 am

    Personalized medicine is at the frontier of health care. The very best clinical molecular labs are developing programs that update molecular results as variants of “unknown significance” become “significant.” However, the ethical considerations of sequencing and incidental findings( those unrelated to the reason for testing, but potentially actionable) continue to consume massive debate. Consider, for example, the finding of a genes related to breast or colon cancer in an infant? What to do?


Leave a Reply

Your email address will not be published.